CorEvitas International Adolescent Alopecia Areata (AA) Drug Safety and Effectiveness Registry
ConditionAlopecia Areata
Trial statusRecruiting
Trial phaseNot listed
Trial typeObservational
Biological sexAll
Age12-17
SponsorCorEvitas
About this trial
Prospective observational registry focusing on an adolescent cohort diagnosed with severe alopecia areata,receiving routine care from dermatology providers. Visit schedules for patients will be determined by the provider in accordance with routine clinical care, and any prescriptions provided to patients will adhere to product availability and local prescribing guidelines/regulations in the country where the participating registry site is located.
Eligibility criteria
Qualifiers
Has ever been diagnosed with severe AA by a dermatologist or a qualified dermatology provider.
Is 12-17 years of age at the time of enrollment.
Is willing to provide consent/assent for participation in the registry.
Has been prescribed a new commercially available advanced therapy and/or conventional systemic therapy for the treatment of severe AA in adolescents in the context of routine clinical care that is consistent with local prescribing guidelines and/or regulations for the country where the site is located.
Disqualifiers
Is participating or planning to participate in a blinded clinical trial for any investigational medication.
Is unwilling or unable to provide standing height measurements.
Trial design
Treatments tested in this trial
- Not listed
Trial groups
No trial groups listed
Sponsors and collaborators
Source ClinicalTrials.gov